# OnCo record paper-esphall-imatinib-biondi-lancet-oncol-2012 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-esphall-imatinib-biondi-lancet-oncol-2012/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-esphall-imatinib-biondi-lancet-oncol-2012" ;
  schema:name "EsPhALL: imatinib after induction for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukaemia"@en ;
  schema:description "In this European trial, adding intermittent imatinib to intensive chemotherapy for childhood Philadelphia-positive leukaemia improved disease-free survival in good-risk patients and supported its use in every child with the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-esphall-imatinib-biondi-lancet-oncol-2012/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(12)70377-7>, <https://pubmed.ncbi.nlm.nih.gov/22898679/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(12)70377-7> ;
  schema:datePublished "2012"^^xsd:gYear ;
  schema:author "Biondi A, Schrappe M, De Lorenzo P, et al." ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-ph-positive/> ;
  onco:drugs <https://onco.cc/drugs/imatinib/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .